PPARGC1A and Hepatic steatosis: Taken together, the increase in the AMPK-PGC1α axis observed in exercised obese dams appears to be substantially involved in mediating the reduction in hepatic steatosis via increased mitochondrial fatty acid oxidation and inhibition of lipogenesis.